pillbase.ru

Eribulin Mesylate

Active substance: eribulin

INJECTION · ERIBULIN MESYLATE .5 mg/mL

United StatesActive

Marketing holder: Sandoz Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 3
  • Eribulin Baxter
    Eribulin mesylate
    EMEA/H/C/006191
    Baxter Holding B.V.
  • Halaven
    Eribulin
    EMEA/H/C/002084
    Eisai GmbH
  • Mevlyq
    Eribulin mesylate
    EMEA/H/C/006134
    YES Pharmaceutical Development Services GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5895-76e7-a2c1-e3ea26660d20,01a1208c-f5e5-76b5-9912-54859393b74e,01a1208d-1b5f-7ae9-8e8c-2e97b76b6695,01a1208d-63a9-7357-a60a-32a9df7935c2,01a1208d-84d4-74d7-b6d1-86da100ae078;count=17 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0781-3391
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 0781-3391 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0781-3391 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0781-3391 · Verified 2026-10-09 · open in source